Select Page

Olgierd Świerzewski

Attorney at Law, Partner, Executive Director, Head of Technology Transactions Practice, Financial Services and Pharmaceuticals Health Care & Life Sciences

Olgierd Świerzewski
phone:
+48 22 326 9600
mobile:
+48 788 262 267
office:
Warsaw

Technology Transactions & Financial Services

Olgierd is a partner and Chair in the Technology Transactions group and has been recognised as a Recommended Lawyer in the “Banking and Finance” sector by the Legal500. He was also nominated as In-house Legal of the Year in 2018 by prestigious magazine The Lawyer, and is also a Project Management Professional certified by the most prestigious global project management organization, the Project Management Institute.

Olgierd has extensive experience in regulatory risk management and conducting analyses and assessments of the impact of regulatory changes on company operations. He has coordinated numerous projects related to anticipating legal risk and assessment of the impact of new legislation on business, i.a. for the Government of the Republic of Poland, the Organization for Economic Cooperation and Development and also within pharmaceutical and IT companies and banks from the private sector.

His practice focuses primarily on technology transactions and transfers, fundraising and financing, joint ventures, technology procurement, outsourcing, and advising on data protection, and the regulatory aspects of digital business.

Olgierd also spent 8 years as General Counsel for Accor Hotels with responsibility for 16 countries in Europe, including the implementation of GDPR requirements, and in addition has worked in-house on secondment to IT giant Dell.

Olgierd has significant experience in advising in M&A transactions (to, among others: Starbucks Coffee, BP Poland, Teich, Aviko, Royal Cosun, Caparo Engineering, PKP Cargo, UGI Corporation, Varian Medical Technologies, Bravura Solutions, IFS, Hanseatic Capital, AccorHotels), as well as in the area of Facility Agreements and Regulatory Finance (i.a. the Royal Bank of Scotland, Barclays, Kaupthing Bank, UBS International, WestLB, GE Bank, the Bank of China).

Languages: Polish, English, Russian.

Membership: The Warsaw Bar Association, Project Management Institute.

Education: The Warsaw University (Master of Law, 1995), The Warsaw School of Economics (Postgraduate studies on Management & Marketing). Project Management Professional certified by PMI.

Recommendations: Recommended Lawyer in the “Banking and Finance” sector by the Legal500. He was also nominated as In-house Lawyer of the Year in 2018 by prestigious magazine The Lawyer.

Pharmaceuticals Health Care & Life Sciences

Olgierd has extensive experience in regulatory risk management and in analysing and assessing the impact of regulatory changes on company operations.

He has coordinated numerous projects related to anticipating legal risk and assessment of the impact of new legislation on business, i.a. for government authorities of the Republic of Poland, the Organization for Economic Cooperation and Development, and pharmaceutical companies.

Olgierd has advised, among others, on the legal aspects of drug reimbursement, clinical trials, authorisation of medicinal products, advertising and promotional activities, distribution, international expansion, protection of industrial property rights, interpretation of Community regulations and directives in the context of Polish legislation. He has also advised on cooperation and joint venture agreements and transactions, and project management.

During his professional career Olgierd has advised both Polish and foreign clients from the pharmaceutical sector, including:

  • GlaxoSmithKline, Novartis,
  • Sanofi Synthelabo, Polpharma S.A.,
  • KRKA Polska Sp. z o.o., BIOTON S.A.
  • Wyeth Pharmaceuticals Ltd.,
  • Superpharm Poland Sp. z o.o.,
  • Grifols Polska Sp. z o.o.,
  • Dr August Wolff Bielefeld GmbH,
  • International Nephrology Centers Poland Sp. z o.o.,
  • Biotechnology Company Ltd.,
  • Ferring, Blaufarma Sp. z o.o.,
  • Polfa Pabianice S.A.,
  • Medicover Sp. z o.o.,
  • Ergomed Sp. z o.o.,
  • Heraeus Medical GmbH,
  • Pharmaco International Holdings Ltd.,
  • Varian Medical Technologies Ltd.,
  • Medimedia International Ltd.,
  • Farma Biagini S.P.A.,
  • Kutnowskie Zakłady Farmaceutyczne „Polfa” S.A. (currently Teva).

His legal advice has covered issues such as:

  • clinical trials of medicinal products and medical devices,
  • drug registration and post-registration changes,
  • cooperation with pharmacies,
  • advertising of medicines and dietary supplements,
  • Regulatory Compliance,
  • proceedings before the Main Pharmaceutical Inspector (GIF), the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL), the Ministry of Health, and pharmaceutical law matters,
  • industry codes of good practice,
  • medical incidents,
  • reimbursement of medicinal products, medical devices and foodstuffs for particular nutritional uses.

Languages: Polish, English, Russian.

Membership: The Warsaw Bar Association, Project Management Institute.

Education: The Warsaw University (Master of Law, 1995), The Warsaw School of Economics (Postgraduate studies on Management & Marketing). Project Management Professional certified by PMI.

Recommendations: Recommended Lawyer in the "Banking and Finance" sector by the Legal500. He was also nominated as In-house Lawyer of the Year in 2018 by prestigious magazine The Lawyer.